“…The ␣ subunit consists of a cytoplasmic domain of limited size, whereas the  subunit consists of a more extensive intracellular domain with multiple tyrosine residues that are targets for phosphorylation by tyrosine kinases including Janus kinase (JAK), to result in the recruitment of Src homology 2 (SH2)-containing proteins to this receptor subunit (14). After ligand binding and the assembly of the high affinity GM-CSF receptor, tyrosine kinases such as JAK2 are recruited to the intracellular domain of the  receptor to activate the JAK͞signal transducer and activator of transcription (STAT), ras͞mitogen-activated protein (MAP) kinase and phosphatidylinositol 3-kinase (PI3-kinase) pathways, leading to increases in the proliferation, maturation, survival, and activation of myeloid and monocyte lineages (1,(7)(8)(9)13). Because a subset of GM-CSF receptors preexists as heterodimers in the absence of ligand binding (14), mechanisms are likely opera- tive that prevent the activation of this receptor in the absence of tissue injury.…”